Keyphrases
Molecular Switches
41%
Neuroblastoma Cells
41%
Fulvestrant
40%
Phosphotyrosine
35%
Enhancer Regulation
33%
Proteomics
33%
Nerve Growth Factor
33%
Ewing Sarcoma
33%
Osimertinib
33%
Consensus Mechanism
33%
Pharmacodynamics
33%
Fibroblast Growth Factor Receptor 2 (FGFR2)
33%
Inhibitory Role
33%
Pharmacokinetics
33%
Glioblastoma
33%
Receptor Trafficking
33%
Signaling Network
33%
Nuclear factor-κB
33%
CI-1033
33%
ErbB Signaling
33%
Patient-derived Xenograft
33%
Neuroblastoma
33%
Antiestrogen
33%
Drug Development
33%
Tropomyosin Receptor Kinase B
33%
E3 Ligase
33%
Resistant Breast Cancer
33%
FGF Receptor
33%
Resistant Cells
33%
Breast Cancer Cells
33%
Erlotinib
33%
Functional Proteomics
33%
Oncogenic mutations
33%
IRS2
33%
Cell Differentiation
33%
Protein Recruitment
33%
Cell Survival
33%
Signaling Pathway
33%
Anaplastic Lymphoma Kinase
33%
Mass Spectrometry
30%
Estrogen Receptor Signaling
26%
Drug Response
22%
FGF10
20%
Protein Signaling
19%
Phosphoproteomics
18%
Therapeutic Potential
17%
Cellular Response
17%
Phosphorylation
17%
Functional Annotation
16%
Lung Tissue
16%
Biochemistry, Genetics and Molecular Biology
Proteomics
100%
Epidermal Growth Factor Receptor
72%
Cancer Cell
43%
Mass Spectrometry
41%
Cell Growth
39%
Cell Survival
36%
Ewing Sarcoma
33%
Drug Screening
33%
Cellular Differentiation
33%
Nerve Growth Factor
33%
RNA Sequence
33%
Genetics
33%
Ubiquitin Ligase
33%
Pharmacodynamics
33%
Anaplastic Lymphoma Kinase
33%
Fibroblast Growth Factor Receptor
33%
Mouse Model
33%
Insulin Receptor
33%
Interaction Proteomics
33%
Exome Sequencing
33%
Fibroblast Growth Factor Receptor 2
33%
Erlotinib
33%
Pharmacokinetic
33%
Enhancer Region
33%
Embryonic Stem Cell
33%
Tropomyosin
33%
Signaling Protein
27%
Transcription Factor
27%
Tyrosine
26%
Gene Mutation
22%
extracellular signal regulated kinase
22%
Drug Distribution
22%
Tyrosine Phosphorylation
21%
Phosphoproteomics
16%
Endoderm
16%
Mediator
16%
Transcription
16%
Mass Spectrometry
16%
Fulvestrant
16%
Phosphopeptide
16%
Medicine and Dentistry
Neoplasm
40%
Ewing Sarcoma
33%
Triple Negative Breast Cancer
33%
ErbB
33%
Antiestrogen
33%
Cancer Cell
33%
Epidermal Growth Factor Receptor
33%
Insulin Receptor Substrate 2
33%
Breast Cancer
33%
Drug Screening
33%
Cell Growth
19%
Protein Tyrosine Kinase
19%
Tamoxifen
18%
RNA Sequence
16%
Exome Sequencing
16%
